Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A C Fluit

Showing results (41-50 of 178) with videos related to

Pageof 18
Sort By:
Antimicrobial Agents and Chemotherapy|March 18, 2000
In vitro activities of sitafloxacin (DU-6859a) and six other fluoroquinolones against 8,796 clinical bacterial isolatesD Milatovic, F J Schmitz, S Brisse, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 3, 2000
Molecular analyses of possible mechanisms coding for low-level mupirocin resistance in clinical Staphylococcus aureus isolatesF J Schmitz, A C Fluit, E Lindenlauf, et al.
The Journal of Antimicrobial Chemotherapy|June 6, 2000
Typing of 154 clinical isolates of Stenotrophomonas maltophilia by pulsed-field gel electrophoresis and determination of the in vitro susceptibilities of these strains to 28 antibioticsF J Schmitz, R Sadurski, J Verhoef, et al.
FEBS Letters|January 18, 1993
Comment to Knoop et al. (1990) FEBS Letters 267, 9-12, toxin B of Clostridium difficile does not have enolase activityA C Fluit, M J Wolfhagen, M Jansze, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 17, 2002
Comparison of E test and double disk diffusion test for detection of extended spectrum beta-lactamasesA Florijn, S Nijssen, F-J Schmitz, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 8, 2000
Epidemiology of quinolone resistance of Klebsiella pneumoniae and Klebsiella oxytoca in EuropeS Brisse, D Milatovic, A C Fluit, et al.
International Journal of Antimicrobial Agents|November 17, 2001
Molecular surveillance of macrolide, tetracycline and quinolone resistance mechanisms in 1191 clinical European Streptococcus pneumoniae isolatesF J Schmitz, M Perdikouli, A Beeck, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 12, 2001
In vitro development of resistance to newer fluoroquinolones in Streptococcus pneumoniae isolates with reduced susceptibility to ciprofloxacinS Mayer, M Boos, K Köhrer, et al.
The Journal of Antimicrobial Chemotherapy|August 6, 2002
Antimicrobial susceptibility of imipenem-resistant Pseudomonas aeruginosaP G Higgins, A C Fluit, D Milatovic, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 2, 2011
Comparison of the identification of coagulase-negative staphylococci by matrix-assisted laser desorption ionization time-of-flight mass spectrometry and tuf sequencingN Carpaij, R J L Willems, M J M Bonten, et al.
Pageof 18

Showing results (41-50 of 178) with videos related to

Sort By:
Pageof 18
Antimicrobial Agents and Chemotherapy|March 18, 2000
In vitro activities of sitafloxacin (DU-6859a) and six other fluoroquinolones against 8,796 clinical bacterial isolatesD Milatovic, F J Schmitz, S Brisse, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 3, 2000
Molecular analyses of possible mechanisms coding for low-level mupirocin resistance in clinical Staphylococcus aureus isolatesF J Schmitz, A C Fluit, E Lindenlauf, et al.
The Journal of Antimicrobial Chemotherapy|June 6, 2000
Typing of 154 clinical isolates of Stenotrophomonas maltophilia by pulsed-field gel electrophoresis and determination of the in vitro susceptibilities of these strains to 28 antibioticsF J Schmitz, R Sadurski, J Verhoef, et al.
FEBS Letters|January 18, 1993
Comment to Knoop et al. (1990) FEBS Letters 267, 9-12, toxin B of Clostridium difficile does not have enolase activityA C Fluit, M J Wolfhagen, M Jansze, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 17, 2002
Comparison of E test and double disk diffusion test for detection of extended spectrum beta-lactamasesA Florijn, S Nijssen, F-J Schmitz, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 8, 2000
Epidemiology of quinolone resistance of Klebsiella pneumoniae and Klebsiella oxytoca in EuropeS Brisse, D Milatovic, A C Fluit, et al.
International Journal of Antimicrobial Agents|November 17, 2001
Molecular surveillance of macrolide, tetracycline and quinolone resistance mechanisms in 1191 clinical European Streptococcus pneumoniae isolatesF J Schmitz, M Perdikouli, A Beeck, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 12, 2001
In vitro development of resistance to newer fluoroquinolones in Streptococcus pneumoniae isolates with reduced susceptibility to ciprofloxacinS Mayer, M Boos, K Köhrer, et al.
The Journal of Antimicrobial Chemotherapy|August 6, 2002
Antimicrobial susceptibility of imipenem-resistant Pseudomonas aeruginosaP G Higgins, A C Fluit, D Milatovic, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 2, 2011
Comparison of the identification of coagulase-negative staphylococci by matrix-assisted laser desorption ionization time-of-flight mass spectrometry and tuf sequencingN Carpaij, R J L Willems, M J M Bonten, et al.
Pageof 18